HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: R800007-MCP200v1 7/10/1824    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Google Scholar Articles by Edwards, A. V. G. Articles by Cordwell, S. J. PubMed PubMed Citation Articles by Edwards, A. V. G. Articles by Cordwell, S. J. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 7:1824-1837, 2008.
© 2008 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Review

The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery^*

Alistair V. G. Edwards^,, Melanie Y. White^¶,||,** and Stuart J. Cordwell^,,¶,

From the Discipline of Pathology, School of Medical Sciences, ^¶ School of Molecular and Microbial Biosciences, University of Sydney, New South Wales, 2006, Australia and the ^|| Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21224

Cardiovascular disease remains the most common cause of death in the developed world and is predicted by the World Health Organization to kill 20 million people worldwide each year until at least 2015. In light of these figures, work on producing superior tools for clinical use in the cardiovascular field is intensive. As proteins are the primary effectors of cellular function, a significant majority of this work focuses on the role of proteins in the cardiovascular system in physiological and pathological states in order to outline both mechanisms and markers of disease. One of the most effective ways to investigate these on a global basis is through proteomic analysis, which allows for broad spectrum screening of cellular protein or peptide complements during cardiovascular pathogenesis. Furthermore, specific technologies are now available to screen animal model or human blood samples for novel, improved markers of chronic disease states, such as atherosclerosis or for earlier indicators of acute myocardial stress, including ischemia/reperfusion injury and heart failure. This review summarizes current literature on the key aspects of proteomics and peptidomics related to clinical cardiovascular science.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?